These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22728103)

  • 21. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.
    Dudra-Jastrzebska M; Andres-Mach MM; Sielski M; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
    Eur J Pharmacol; 2009 Mar; 605(1-3):87-94. PubMed ID: 19168049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome.
    Martínez-Cué C; Rueda N; García E; Flórez J
    Genes Brain Behav; 2006 Jul; 5(5):413-22. PubMed ID: 16879635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible involvement of GABAergic modulation in the protective effect of gabapentin against immobilization stress-induced behavior alterations and oxidative damage in mice.
    Kumar A; Goyal R
    Fundam Clin Pharmacol; 2007 Dec; 21(6):575-81. PubMed ID: 18034658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome.
    Shichiri M; Yoshida Y; Ishida N; Hagihara Y; Iwahashi H; Tamai H; Niki E
    Free Radic Biol Med; 2011 Jun; 50(12):1801-11. PubMed ID: 21447382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model.
    Harashima C; Jacobowitz DM; Stoffel M; Chakrabarti L; Haydar TF; Siarey RJ; Galdzicki Z
    Cell Mol Neurobiol; 2006; 26(4-6):719-34. PubMed ID: 16783527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
    Corrales A; Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Diego M; Wilhem Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
    Behav Brain Res; 2017 Sep; 334():142-154. PubMed ID: 28743603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice.
    Nieoczym D; Socała K; Luszczki JJ; Czuczwar SJ; Wlaź P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):129-35. PubMed ID: 22683320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn.
    Kida E; Rabe A; Walus M; Albertini G; Golabek AA
    Exp Neurol; 2013 Feb; 240():178-89. PubMed ID: 23201095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model.
    Möhler H
    Biochem Pharmacol; 2012 Oct; 84(8):994-9. PubMed ID: 22898099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate and delayed treatment with gabapentin, carbamazepine and CNQX have almost similar impact on cognitive functions and behavior in the lithium-pilocarpine model in rats.
    Gulec Suyen G; Isbil-Buyukcoskun N; Kahveci N; Sengun E; Ozluk K
    Pharmacol Biochem Behav; 2016 Sep; 148():128-35. PubMed ID: 27426469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action.
    Ng GY; Bertrand S; Sullivan R; Ethier N; Wang J; Yergey J; Belley M; Trimble L; Bateman K; Alder L; Smith A; McKernan R; Metters K; O'Neill GP; Lacaille JC; Hébert TE
    Mol Pharmacol; 2001 Jan; 59(1):144-52. PubMed ID: 11125035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
    García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
    PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboxylate bioisosteres of gabapentin.
    Burgos-Lepley CE; Thompson LR; Kneen CO; Osborne SA; Bryans JS; Capiris T; Suman-Chauhan N; Dooley DJ; Donovan CM; Field MJ; Vartanian MG; Kinsora JJ; Lotarski SM; El-Kattan A; Walters K; Cherukury M; Taylor CP; Wustrow DJ; Schwarz JB
    Bioorg Med Chem Lett; 2006 May; 16(9):2333-6. PubMed ID: 15946842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.
    Escorihuela RM; Fernández-Teruel A; Vallina IF; Baamonde C; Lumbreras MA; Dierssen M; Tobeña A; Flórez J
    Neurosci Lett; 1995 Oct; 199(2):143-6. PubMed ID: 8584244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreasing the Expression of GABA
    Vidal V; García-Cerro S; Martínez P; Corrales A; Lantigua S; Vidal R; Rueda N; Ozmen L; Hernández MC; Martínez-Cué C
    Mol Neurobiol; 2018 Jun; 55(6):4745-4762. PubMed ID: 28717969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of gabapentin against the seizure susceptibility and comorbid behavioral abnormalities in the early socially isolated mice.
    Amiri S; Haj-Mirzaian A; Amini-Khoei H; Razmi A; Shirzadian A; Rahimi-Balaei M; Olson CO; Mohsenzadeh A; Rastegar M; Zarrindast MR; Ghazi-Khansari M
    Eur J Pharmacol; 2017 Feb; 797():106-114. PubMed ID: 28115172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.